GSK Investigational Site

Conway, Arkansas 72034

0 studies enrolling now · 5 studies all time

What they study most

Influenza, Measles, Measles-Mumps-Rubella Vaccine, Migraine Disorders, Mumps, Pulmonary Disease, Chronic Obstructive, Rubella

Studies at this site

• Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed
• Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age — Completed
• Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children — Completed
• Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age — Completed
• Migraine Study in Adolescent Patients — Completed